A Promising Role of TGF-β Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report

A Promising Role of TGF-β Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report

Colorectal cancer (CRC) is one of the most common cancer types around the world. The prognosis of patients with advanced diseases is still poor in spite of currently available therapeutic options. Regorafenib is an oral tyrosine kinase inhibitor (TKI) approved to treat refractory metastatic colorect...

Full description

Bibliographic Details
Main Authors: Simona De Summa, Katia Danza, Brunella Pilato, Giuseppina Matera, Rossella Fasano, Angela Calabrese, Rosanna Lacalamita, Nicola Silvestris, Stefania Tommasi, Antonella Argentiero, Oronzo Brunetti
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Medicina
Subjects:
colorectal cancer
TGF-b
regorafenib
Online Access:https://www.mdpi.com/1648-9144/57/11/1241

Internet

https://www.mdpi.com/1648-9144/57/11/1241

Similar Items